Radioprotective Effects of Dermatan Sulfate in a Preclinical Model of Oral Mucositis—Targeting Inflammation, Hypoxia and Junction Proteins without Stimulating Proliferation
Oral mucositis is the most frequently occurring early side effect of head-and-neck cancer radiotherapy. Systemic dermatan sulfate (DS) treatment revealed a significant radioprotective potential in a preclinical model of oral mucositis. This study was initiated to elucidate the mechanistic effects of...
Main Authors: | Sylvia Gruber, Marlene Arnold, Nilsu Cini, Victoria Gernedl, Sabine Hetzendorfer, Lisa-Marie Kowald, Peter Kuess, Julia Mayer, Susanne Morava, Stephanie Pfaffinger, Andreas Rohorzka, Wolfgang Dörr |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/19/6/1684 |
Similar Items
-
Pathophysiological Significance of Dermatan Sulfate Proteoglycans Revealed by Human Genetic Disorders
by: Shuji Mizumoto, et al.
Published: (2017-03-01) -
A Possible Role for Arylsulfatase G in Dermatan Sulfate Metabolism
by: Aleksandra Poterala-Hejmo, et al.
Published: (2020-07-01) -
Research and Application of Chondroitin Sulfate/Dermatan Sulfate-Degrading Enzymes
by: Wenshuang Wang, et al.
Published: (2020-12-01) -
A Fluorescent Probe for Glycosaminoglycans Applied to the Detection of Dermatan Sulfate by a Mix-and-Read Assay
by: Melissa Rappold, et al.
Published: (2017-05-01) -
Comparative Study of Two Chondroitin Sulfate/Dermatan Sulfate 4-O-Sulfatases With High Identity
by: Shumin Wang, et al.
Published: (2019-06-01)